|
1
|
Tønnesen E and Larsen K: Severe sepsis and
septic shock. Ugeskr Laeger. 176:V031302002014.(In Danish).
PubMed/NCBI
|
|
2
|
Sharawy N and Lehmann C: New directions
for sepsis and septic shock research. J Surg Res. 194:520–527.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cao Z and Robinson RA: The role of
proteomics in understanding biological mechanisms of sepsis.
Proteomics Clin Appl. 8:35–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sato R and Nasu M: A review of
sepsis-induced cardiomyopathy. J Intensive Care. 3:482015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sato R, Kuriyama A, Takada T, Nasu M and
Luthe SK: Prevalence and risk factors of sepsis-induced
cardiomyopathy: A retrospective cohort study. Medicine (Baltimore).
95:e50312016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hobai IA, Edgecomb J, LaBarge K and
Colucci WS: Dysregulation of intracellular calcium transporters in
animal models of sepsis-induced cardiomyopathy. Shock. 43:3–15.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Romero-Bermejo FJ, Ruiz-Bailen M,
Gil-Cebrian J and Huertos-Ranchal MJ: Sepsis-induced
cardiomyopathy. Curr Cardiol Rev. 7:163–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lv X and Wang H: Pathophysiology of
sepsis-induced myocardial dysfunction. Mil Med Res. 3:302016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Espín-Pérez A, Krauskopf J, Chadeau-Hyam
M, van Veldhoven K, Chung F, Cullinan P, Piepers J, van Herwijnen
M, Kubesch N, Carrasco-Turigas G, et al: Short-term transcriptome
and microRNAs responses to exposure to different air pollutants in
two population studies. Environ Pollut. 242:182–190. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bernardo BC, Ooi JY, Lin RC and McMullen
JR: miRNA therapeutics: A new class of drugs with potential
therapeutic applications in the heart. Future Med Chem.
7:1771–1792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou F, Wang W, Xing Y, Wang T, Xu X and
Wang J: NF-κB target microRNAs and their target genes in
TNFα-stimulated HeLa cells. Biochim Biophys Acta. 1839:344–354.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu ZW, Liu YF, Wang S and Li B: miRNA-146a
induces vascular smooth muscle cell apoptosis in a rat model of
coronary heart disease via NF-κB pathway. Genet Mol Res.
14:18703–18712. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Ha T, Liu L, Zou J, Zhang X,
Kalbfleisch J, Gao X, Williams D and Li C: Increased expression of
microRNA-164a decreases myocardial ischemia/reperfusion injury.
Cardiovasc Res. 97:432–442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao M, Wang X, Zhang X, Ha T, Ma H, Liu L,
Kalbfleisch JH, Gao X, Kao RL, Williams DL and Li C: Attenuation of
cardiac dysfunction in polymicrobial sepsis by microRNA-146a is
mediated via targeting of IRAK1 and TRAF6 expression. J Immunol.
195:672–682. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taganov KD, Boldin MP, Chang KJ and
Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune
responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun W, Wang Q, Guo Y, Zhao Y, Wang X,
Zhang Z, Deng G and Guo M: Selenium suppresses inflammation by
inducing microRNA-146a in Staphylococcus aureus-infected mouse
mastitis model. Oncotarget. 8:110949–110964. 2017.PubMed/NCBI
|
|
17
|
Wu ZW, Liu YF, Wang S and Li B:
Corrigendum miRNA-146a induces vascular smooth muscle cell
apoptosis in a rat model of coronary heart disease via NF-κB
pathway-Genet. Mol. Res. 14(4): 18703–18712, Genet Mol Res 15.
2016. View Article : Google Scholar
|
|
18
|
Li J, Xie C, Zhuang J, Li H, Yao Y, Shao C
and Wang H: Resveratrol attenuates inflammation in the rat heart
subjected to ischemia-reperfusion: Role of the TLR4/NF-κB signaling
pathway. Mol Med Rep. 11:1120–1126. 2015.PubMed/NCBI
|
|
19
|
Karra R, Knecht AK, Kikuchi K and Poss KD:
Myocardial NF-κB activation is essential for zebrafish heart
regeneration. Proc Natl Acad Sci USA. 112:13255–13260. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang SF, Zhuang TF, Si YM, Qi KY and Zhao
J: Coriolus versicolor mushroom polysaccharides exert
immunoregulatory effects on mouse B cells via membrane Ig and TLR-4
to activate the MAPK and NF-κB signaling pathways. Mol Immunol.
64:144–151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim E, Kim HC, Lee S, Ryu HG, Park YH, Kim
JH, Lim YJ and Park HP: Dexmedetomidine confers neuroprotection
against transient global cerebral ischemia/reperfusion injury in
rats by inhibiting inflammation through inactivation of the
TLR-4/NF-κB pathway. Neurosci Lett. 649:20–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bi W, Zhu L, Jing X, Zeng Z, Liang Y, Xu
A, Liu J, Xiao S, Yang L, Shi Q, et al: Rifampicin improves
neuronal apoptosis in LPS-stimulated co-cultured BV2 cells through
inhibition of the TLR-4 pathway. Mol Med Rep. 10:1793–1799. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cimolai MC, Alvarez S, Bode C and Bugger
H: Mitochondrial mechanisms in septic cardiomyopathy. Int J Mol
Sci. 16:17763–17778. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou Q, Pan X, Wang L, Wang X and Xiong D:
The protective role of neuregulin-1: A potential therapy for
sepsis-induced cardiomyopathy. Eur J Pharmacol. 788:234–240. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park H, Huang X, Lu C, Cairo MS and Zhou
X: MicroRNA-146a and microRNA-146b regulate human dendritic cell
apoptosis and cytokine production by targeting TRAF6 and IRAK1
proteins. J Biol Chem. 290:2831–2841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei J, Wang J, Zhou Y, Yan S, Li K and Lin
H: MicroRNA-146a contributes to SCI recovery via regulating TRAF6
and IRAK1 expression. Biomed Res Int. 2016:40134872016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang W and Kong L, Ni Q, Lu Y, Ding W,
Liu G, Pu L, Tang W and Kong L: miR-146a ameliorates liver
ischemia/reperfusion injury by suppressing IRAK1 and TRAF6. PLoS
One. 9:e1015302014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hiram R, Rizcallah E, Sirois C, Sirois M,
Morin C, Fortin S and Rousseau E: Resolvin D1 reverses reactivity
and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human
pulmonary artery. Am J Physiol Heart Circ Physiol. 307:H1547–H1558.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hiram R, Rizcallah E, Marouan S, Sirois C,
Sirois M, Morin C, Fortin S and Rousseau E: Resolvin E1 normalizes
contractility, Ca2+ sensitivity and smooth muscle cell migration
rate in TNF-α- and IL-6-pretreated human pulmonary arteries. Am J
Physiol Lung Cell Mol Physiol. 309:L776–L788. 2015.PubMed/NCBI
|
|
31
|
Dumache R, Rogobete AF, Bedreag OH,
Sarandan M, Cradigati AC, Papurica M, Dumbuleu CM, Nartita R and
Sandesc D: Use of miRNAs as biomarkers in sepsis. Anal Cell Pathol
(Amst). 2015:1867162015.PubMed/NCBI
|
|
32
|
Landskroner-Eiger S, Moneke I and Sessa
WC: miRNAs as modulators of angiogenesis. Cold Spring Harb Perspect
Med. 3:a0066432013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou S, Zhang P, Liang P and Huang X: The
expression of miR-125b regulates angiogenesis during the recovery
of heat-denatured HUVECs. Burns. 41:803–811. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feng J, Yang Y, Zhang P, Wang F, Ma Y, Qin
H and Wang Y: miR-150 functions as a tumour suppressor in human
colorectal cancer by targeting c-Myb. J Cell Mol Med. 18:2125–2134.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Slezak-Prochazka I, Kluiver J, de Jong D,
Smigielska-Czepiel K, Kortman G, Winkle M, Rutgers B, Koerts J,
Visser L, Diepstra A, et al: Inhibition of the miR-155 target NIAM
phenocopies the growth promoting effect of miR-155 in B-cell
lymphoma. Oncotarget. 7:2391–2400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meloche J, Le Guen M, Potus F, Vinck J,
Ranchoux B, Johnson I, Antigny F, Tremblay E, Breuils-Bonnet S,
Perros F, et al: miR-223 reverses experimental pulmonary arterial
hypertension. Am J Physiol Cell Physiol. 309:C363–C372. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hadar A, Milanesi E, Walczak M,
Puzianowska-Kuźnicka M, Kuźnicki J, Squassina A, Niola P, Chillotti
C, Attems J, Gozes I and Gurwitz D: SIRT1, miR-132 and miR-212 link
human longevity to Alzheimer's Disease. Sci Rep. 8:84652018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bae SC and Lee YH: MiR-146a levels in
rheumatoid arthritis and their correlation with disease activity: A
meta-analysis. Int J Rheum Dis. 21:1335–1342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu Q, Song J, Ding B, Cui Y, Liang J and
Han S: miR-146a promotes cervical cancer cell viability via
targeting IRAK1 and TRAF6. Oncol Rep. 39:3015–3024. 2018.PubMed/NCBI
|
|
40
|
Zhang QB, Qing YF, Yin CC, Zhou L, Liu XS,
Mi QS and Zhou JG: Mice with miR-146a deficiency develop severe
gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3
inflammasome. Arthritis Res Ther. 20:452018. View Article : Google Scholar : PubMed/NCBI
|
